131 related articles for article (PubMed ID: 38145333)
1. Economic evidence supports the cost savings of sputum eosinophil counts to guide the treatment of pediatrics patients with persistent asthma: implications for clinical practice guidelines in middle-income countries.
Buendía JA; Guerrero Patiño D; Zuluaga Salazar AF
J Asthma; 2024 Jul; 61(7):671-676. PubMed ID: 38145333
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the Budget Impact of Fractional Exhaled Nitric Oxide Monitoring in the Management of Childhood Asthma: The Colombian National Health System Perspective.
Buendía JA; Acuña-Cordero R; Rodriguez-Martinez CE
J Investig Allergol Clin Immunol; 2022 Jun; 32(3):200-205. PubMed ID: 33847566
[TBL] [Abstract][Full Text] [Related]
3. Cost-utility of use of sputum eosinophil counts to guide management in children with asthma.
Buendía JA; Talamoni HL
J Asthma; 2022 Jan; 59(1):31-37. PubMed ID: 33026885
[TBL] [Abstract][Full Text] [Related]
4. Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis.
Buendía JA; Guerrero Patiño D; Sánchez Caraballo JM
BMC Pulm Med; 2022 Jun; 22(1):257. PubMed ID: 35765011
[TBL] [Abstract][Full Text] [Related]
5. Budget impact analysis of high-flow nasal cannula for infant bronchiolitis: the Colombian National Health System perspective.
Buendía JA; Acuña-Cordero R; Rodriguez-Martinez CE
Curr Med Res Opin; 2021 Sep; 37(9):1627-1632. PubMed ID: 34130560
[TBL] [Abstract][Full Text] [Related]
6. Budget Impact Analysis of Hypertonic Saline Inhalations for Infant Bronchiolitis: The Colombian National Health System Perspective.
Buendía JA; Patiño DG
Value Health Reg Issues; 2022 Mar; 28():14-18. PubMed ID: 34800827
[TBL] [Abstract][Full Text] [Related]
7. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
Petsky HL; Li A; Chang AB
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils).
Petsky HL; Cates CJ; Lasserson TJ; Li AM; Turner C; Kynaston JA; Chang AB
Thorax; 2012 Mar; 67(3):199-208. PubMed ID: 20937641
[TBL] [Abstract][Full Text] [Related]
9. Relationship between induced sputum cell counts and fluid-phase eosinophil cationic protein and clinical or physiologic profiles in mild asthma.
Gutiérrez V; Prieto L; Torres V; Trenor R; Pérez C; Bertó JM; Marín J
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):559-65. PubMed ID: 10400484
[TBL] [Abstract][Full Text] [Related]
10. Full blood count parameters for the detection of asthma inflammatory phenotypes.
Zhang XY; Simpson JL; Powell H; Yang IA; Upham JW; Reynolds PN; Hodge S; James AL; Jenkins C; Peters MJ; Lin JT; Gibson PG
Clin Exp Allergy; 2014 Sep; 44(9):1137-45. PubMed ID: 24849076
[TBL] [Abstract][Full Text] [Related]
11. Correlation of induced sputum eosinophil levels with clinical parameters in mild and moderate persistent asthma in children aged 7-18 years.
Kansal P; Nandan D; Agarwal S; Patharia N; Arya N
J Asthma; 2018 Apr; 55(4):385-390. PubMed ID: 28696802
[TBL] [Abstract][Full Text] [Related]
12. Are sputum eosinophil cationic protein and eosinophils differently associated with clinical and functional findings of asthma?
Cianchetti S; Bacci E; Ruocco L; Pavia T; Bartoli ML; Cardini C; Costa F; Di Franco A; Malagrinò L; Novelli F; Vagaggini B; Celi A; Dente F; Paggiaro P
Clin Exp Allergy; 2014; 44(5):673-80. PubMed ID: 24245689
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of inflammatory biomarkers in asthma: exhaled nitric oxide and induced sputum eosinophil count.
Fortuna AM; Feixas T; González M; Casan P
Respir Med; 2007 Nov; 101(11):2416-21. PubMed ID: 17714927
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Economic Burden of Elevated Blood Eosinophils in Patients With and Without Uncontrolled Asthma.
Casciano J; Krishnan J; Dotiwala Z; Li C; Sun SX
J Manag Care Spec Pharm; 2017 Jan; 23(1):85-91. PubMed ID: 28025926
[TBL] [Abstract][Full Text] [Related]
15. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
Petsky HL; Kynaston JA; Turner C; Li AM; Cates CJ; Lasserson TJ; Chang AB
Cochrane Database Syst Rev; 2007 Apr; (2):CD005603. PubMed ID: 17443604
[TBL] [Abstract][Full Text] [Related]
16. Value of peripheral blood eosinophil markers to predict severity of asthma.
Casciano J; Krishnan JA; Small MB; Buck PO; Gopalan G; Li C; Kemp R; Dotiwala Z
BMC Pulm Med; 2016 Jul; 16(1):109. PubMed ID: 27473851
[TBL] [Abstract][Full Text] [Related]
17. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects.
Hastie AT; Moore WC; Li H; Rector BM; Ortega VE; Pascual RM; Peters SP; Meyers DA; Bleecker ER;
J Allergy Clin Immunol; 2013 Jul; 132(1):72-80. PubMed ID: 23706399
[TBL] [Abstract][Full Text] [Related]
18. Correlation of eosinophil counts in induced sputum and fractional concentration of exhaled nitric oxide and lung functions in patients with mild to moderate asthma.
Wang W; Huang KW; Wu BM; Wang YJ; Wang C
Chin Med J (Engl); 2012 Sep; 125(17):3157-60. PubMed ID: 22932198
[TBL] [Abstract][Full Text] [Related]
19. Budget impact analysis of surfactant therapy for bronchiolitis in critically ill infants: the Colombian National Health System perspective.
Buendía JA; Patiño DG
BMC Health Serv Res; 2021 Apr; 21(1):334. PubMed ID: 33849521
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
